HyperSBINN: A Hypernetwork-Enhanced Systems Biology-Informed Neural Network for Efficient Drug Cardiosafety Assessment
0
Sign in to get full access
Overview
- A hypernetwork-enhanced systems biology-informed neural network for efficient drug cardiosafety assessment
- Combines systems biology models with deep learning to predict cardiac action potential responses to drugs
- Aims to improve the efficiency and accuracy of pre-clinical drug safety testing
Plain English Explanation
HyperSBINN is a new approach that combines systems biology models of cardiac physiology with deep learning techniques to assess the potential cardiac safety risks of new drugs.
The core idea is to leverage our existing scientific understanding of how the heart works, captured in detailed mathematical models, and use that to guide and enhance the training of a neural network. This allows the neural network to make more accurate predictions about how a drug will affect the heart's electrical activity, which is a key indicator of potential cardiotoxicity.
By incorporating this domain-specific knowledge, the researchers hope to improve the efficiency and reliability of pre-clinical drug safety testing, potentially accelerating the development of new medications.
Technical Explanation
The Cardiac action potential model section describes the detailed biophysical model of cardiac electrophysiology that serves as the foundation for HyperSBINN. This model captures the complex dynamics of ion channels, transporters, and other processes that govern the heart's electrical activity.
The HyperSBINN architecture section explains how this systems biology model is integrated with a deep neural network. The network is designed to take in information about a drug's molecular structure and physiochemical properties, and output predictions about the drug's impact on the cardiac action potential.
A key innovation is the use of a "hypernetwork" that learns to generate the weights and biases of the main neural network, allowing it to adapt its structure based on the input data. This helps the model capture the nonlinear relationships between drug properties and cardiac effects.
Critical Analysis
The paper acknowledges several limitations of the HyperSBINN approach. For example, the model is currently trained and evaluated on a relatively small dataset of drugs, and its performance on a wider range of compounds is yet to be fully assessed.
Additionally, the researchers note that while HyperSBINN can provide valuable insights into potential cardiotoxicity, it does not eliminate the need for further in vitro and in vivo testing. The model's predictions should be viewed as complementary information to guide the drug development process, rather than a replacement for established safety evaluation methods.
Further research may also be needed to fully understand the generalization capabilities of the hypernetwork architecture and how it compares to other neural network designs for this application.
Conclusion
HyperSBINN represents an interesting advancement in the use of systems biology-informed deep learning for drug cardiosafety assessment. By integrating detailed physiological models with powerful machine learning techniques, the researchers have developed a tool that could help make the drug development process more efficient and effective.
While the current implementation has some limitations, the overall approach demonstrates the potential of combining domain-specific scientific knowledge with data-driven modeling to tackle complex problems in biomedicine and pharmacology.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
HyperSBINN: A Hypernetwork-Enhanced Systems Biology-Informed Neural Network for Efficient Drug Cardiosafety Assessment
Inass Soukarieh, Gerhard Hessler, Herv'e Minoux, Marcel Mohr, Friedemann Schmidt, Jan Wenzel, Pierre Barbillon, Hugo Gangloff, Pierre Gloaguen
Mathematical modeling in systems toxicology enables a comprehensive understanding of the effects of pharmaceutical substances on cardiac health. However, the complexity of these models limits their widespread application in early drug discovery. In this paper, we introduce a novel approach to solving parameterized models of cardiac action potentials by combining meta-learning techniques with Systems Biology-Informed Neural Networks (SBINNs). The proposed method, HyperSBINN, effectively addresses the challenge of predicting the effects of various compounds at different concentrations on cardiac action potentials, outperforming traditional differential equation solvers in speed. Our model efficiently handles scenarios with limited data and complex parameterized differential equations. The HyperSBINN model demonstrates robust performance in predicting APD90 values, indicating its potential as a reliable tool for modeling cardiac electrophysiology and aiding in preclinical drug development. This framework represents an advancement in computational modeling, offering a scalable and efficient solution for simulating and understanding complex biological systems.
Read more8/27/2024
0
Learning Chemotherapy Drug Action via Universal Physics-Informed Neural Networks
Lena Podina, Ali Ghodsi, Mohammad Kohandel
Quantitative systems pharmacology (QSP) is widely used to assess drug effects and toxicity before the drug goes to clinical trial. However, significant manual distillation of the literature is needed in order to construct a QSP model. Parameters may need to be fit, and simplifying assumptions of the model need to be made. In this work, we apply Universal Physics-Informed Neural Networks (UPINNs) to learn unknown components of various differential equations that model chemotherapy pharmacodynamics. We learn three commonly employed chemotherapeutic drug actions (log-kill, Norton-Simon, and E_max) from synthetic data. Then, we use the UPINN method to fit the parameters for several synthetic datasets simultaneously. Finally, we learn the net proliferation rate in a model of doxorubicin (a chemotherapeutic) pharmacodynamics. As these are only toy examples, we highlight the usefulness of UPINNs in learning unknown terms in pharmacodynamic and pharmacokinetic models.
Read more4/15/2024
🧠
0
Discovering intrinsic multi-compartment pharmacometric models using Physics Informed Neural Networks
Imran Nasim, Adam Nasim
Pharmacometric models are pivotal across drug discovery and development, playing a decisive role in determining the progression of candidate molecules. However, the derivation of mathematical equations governing the system is a labor-intensive trial-and-error process, often constrained by tight timelines. In this study, we introduce PKINNs, a novel purely data-driven pharmacokinetic-informed neural network model. PKINNs efficiently discovers and models intrinsic multi-compartment-based pharmacometric structures, reliably forecasting their derivatives. The resulting models are both interpretable and explainable through Symbolic Regression methods. Our computational framework demonstrates the potential for closed-form model discovery in pharmacometric applications, addressing the labor-intensive nature of traditional model derivation. With the increasing availability of large datasets, this framework holds the potential to significantly enhance model-informed drug discovery.
Read more5/2/2024
0
Improvement of Bayesian PINN Training Convergence in Solving Multi-scale PDEs with Noise
Yilong Hou, Xi'an Li, Jinran Wu
Bayesian Physics Informed Neural Networks (BPINN) have received considerable attention for inferring differential equations' system states and physical parameters according to noisy observations. However, in practice, Hamiltonian Monte Carlo (HMC) used to estimate the internal parameters of BPINN often encounters troubles, including poor performance and awful convergence for a given step size used to adjust the momentum of those parameters. To improve the efficacy of HMC convergence for the BPINN method and extend its application scope to multi-scale partial differential equations (PDE), we developed a robust multi-scale Bayesian PINN (dubbed MBPINN) method by integrating multi-scale deep neural networks (MscaleDNN) and Bayesian inference. In this newly proposed MBPINN method, we reframe HMC with Stochastic Gradient Descent (SGD) to ensure the most ``likely'' estimation is always provided, and we configure its solver as a Fourier feature mapping-induced MscaleDNN. The MBPINN method offers several key advantages: (1) it is more robust than HMC, (2) it incurs less computational cost than HMC, and (3) it is more flexible for complex problems. We demonstrate the applicability and performance of the proposed method through general Poisson and multi-scale elliptic problems in one- to three-dimensional spaces. Our findings indicate that the proposed method can avoid HMC failures and provide valid results. Additionally, our method can handle complex PDE and produce comparable results for general PDE. These findings suggest that our proposed approach has excellent potential for physics-informed machine learning for parameter estimation and solution recovery in the case of ill-posed problems.
Read more8/20/2024